Similarly, patients with diabetes mellitus type II have been shown to exhibit increased expression of sFRP5, a Wnt inhibitor, which has been correlated with a decrease in Wnt5a levels [55]. This evidence concerns the gene SFRP5 and type 2 diabetes mellitus.